Benefits of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis

作者: Yongquan Tang , Zhihong Liu , Zijun Zou , Jiayu Liang , Yiping Lu

DOI: 10.1155/2018/9362108

关键词:

摘要: Background. The adjuvant use of mitotane on adrenocortical carcinoma (ACC) has always been in controversy. We aimed to assess the prognostic benefits after resection ACC patients without distant metastasis. Methods. PubMed, WoS, Embase, and Cochrane Library databases were systematically searched. Recurrence-free survival (RFS) overall (OS) adopted as measurements. A meta-analysis was conducted based hazard ratio (HR) with 95% confidence interval (CI). study included only if enrolled underwent chemotherapy except mitotane. Results. total 5 retrospective studies reporting 1249 for this meta-analysis. showed that significantly associated prolonged RFS (HR = 0.62; 95%CI, 0.42-0.94; P < 0.05) OS 0.69; 0.55-0.88, 0.05). Conclusion. After comprehensive review, current evidence suggests decreases recurrence rate mortality metastasis, but these findings need further demonstration from prospective controlled trials.

参考文章(38)
H. Du Rostu, J. Guillon, A. Murat, M. Krempf, J. M. Mussini, B. Charbonnel, Neurotoxicité du traitement par le mitotane des cortico-surrénalomes (5 cas) et des syndromes de Cushing (7 cas). Presse Medicale. ,vol. 16, pp. 951- 954 ,(1987)
Vasileios Chortis, Angela E. Taylor, Petra Schneider, Jeremy W. Tomlinson, Beverly A. Hughes, Donna M. O'Neil, Rossella Libé, Bruno Allolio, Xavier Bertagna, Jérôme Bertherat, Felix Beuschlein, Martin Fassnacht, Niki Karavitaki, Massimo Mannelli, Franco Mantero, Giuseppe Opocher, Emilio Porfiri, Marcus Quinkler, Mark Sherlock, Massimo Terzolo, Peter Nightingale, Cedric H. L. Shackleton, Paul M. Stewart, Stefanie Hahner, Wiebke Arlt, Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement The Journal of Clinical Endocrinology and Metabolism. ,vol. 98, pp. 161- 171 ,(2013) , 10.1210/JC.2012-2851
Arnoud P. van Seters, Abraham J. Moolenaar, Mitotane increases the blood levels of hormone-binding proteins. European Journal of Endocrinology. ,vol. 124, pp. 526- 533 ,(1991) , 10.1530/ACTA.0.1240526
Johan Jönsson, Heriberto Rodriguez-Martinez, Ingvar Brandt, Transplacental toxicity of 3-methylsulphonyl-DDE in the developing adrenal cortex in mice Reproductive Toxicology. ,vol. 9, pp. 257- 264 ,(1995) , 10.1016/0890-6238(95)00013-Z
Massimo Terzolo, Alfredo Berruti, Adjunctive treatment of adrenocortical carcinoma. Current Opinion in Endocrinology, Diabetes and Obesity. ,vol. 15, pp. 221- 226 ,(2008) , 10.1097/MED.0B013E3282FDF4C0
Silviu Sbiera, Ellen Leich, Gerhard Liebisch, Iuliu Sbiera, Andreas Schirbel, Laura Wiemer, Silke Matysik, Carolin Eckhardt, Felix Gardill, Annemarie Gehl, Sabine Kendl, Isabel Weigand, Margarita Bala, Cristina L. Ronchi, Timo Deutschbein, Gerd Schmitz, Andreas Rosenwald, Bruno Allolio, Martin Fassnacht, Matthias Kroiss, Mitotane Inhibits Sterol-O-Acyl Transferase 1 Triggering Lipid-Mediated Endoplasmic Reticulum Stress and Apoptosis in Adrenocortical Carcinoma Cells Endocrinology. ,vol. 156, pp. 3895- 3908 ,(2015) , 10.1210/EN.2015-1367
J.W. LATIMER, H.S. SIEGEL, DDT and Metabolite Accumulation in Adrenal, Liver, and Brain of Broiler Chickens Poultry Science. ,vol. 56, pp. 1622- 1626 ,(1977) , 10.3382/PS.0561622
Vendela Asp, Veronica Lindström, Jan A. Olsson, Ulrika Bergström, Ingvar Brandt, Cytotoxicity and decreased corticosterone production in adrenocortical Y-1 cells by 3-methylsulfonyl-DDE and structurally related molecules. Archives of Toxicology. ,vol. 83, pp. 389- 396 ,(2009) , 10.1007/S00204-008-0342-6